Careers at Glycomine Inc

About Glycomine Inc

Glycomine Inc. is focused on developing replacement therapies for rare genetic diseases, with the aim of significantly improving the quality of life for patients and their families. The company's primary focus is on PMM2-CDG, a rare genetic disorder of glycosylation, through its lead drug candidate, GLM101. This mannose-1-phosphate replacement therapy is currently in clinical trials across the U. S. and Europe. Glycomine is committed to providing disease-modifying treatments that go beyond existing therapies that only address symptoms. By advancing their innovative platform, Glycomine aims to restore the missing function caused by genetic mutations in patients with serious rare diseases.